Bulten (BULTEN) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
27 Dec, 2025Executive summary
Q1 2025 net sales declined 6.6% year-over-year, mainly due to lower global vehicle sales, but volumes and operating results were in line with expectations.
Adjusted EBIT margin improved to 6.2% in Q1 2025, up from 5.2% in 2024, despite a SEK 45 million one-time anti-dumping cost.
Engagement with customers and partners remains strong, and a new strategy is being drafted for 2025.
Non-automotive sales grew 16% year-over-year, now representing 13.9% of total sales, and are more profitable.
A SEK 45 million anti-dumping duty on Chinese imports impacted EBIT, with SEK 35 million under appeal.
Financial highlights
Adjusted EBIT for Q1 was SEK 89 million, with a 6.2% margin; currency effects reduced margin to 6.8% from 7.4% last year.
Adjusted EPS was SEK 2.09 for the quarter and SEK 5.3 for the rolling 12 months.
Cash flow from operating activities was SEK 71 million, down from SEK 123 million last year; CapEx outflows increased due to equipment investments.
Net debt stood at SEK 1,383 million at quarter end; liquidity at SEK 847 million including unused credit lines.
Gross profit was SEK 252 million, with a gross margin of 17.6% (down from 20.7%).
Outlook and guidance
Order intake in Q1 was slightly better than last year, with no major volume drops expected in the near term.
Light vehicle market is projected to grow a few percent in 2025, supporting stable volumes.
New strategy and financial targets for 2025 will be set and communicated after board approval.
Management sees room to improve EBIT even in an uncertain market environment.
Latest events from Bulten
- Full-year sales fell 13.1% but Q4 recovery exceeded expectations; no 2025 dividend proposed.BULTEN
Q4 20253 Feb 2026 - Sales and EBIT margin improved, but volatility and cost pressures weighed on profitability.BULTEN
Q2 20243 Feb 2026 - EBIT margin rose to 6.8% in Q3 2024 despite lower sales, aided by cost controls and insurance gain.BULTEN
Q3 202419 Jan 2026 - Full-year sales and margins improved, but Q4 was hit by SEK 55m in one-off costs.BULTEN
Q4 20249 Jan 2026 - Margins held steady despite lower sales, with growth in high-margin medtech and electronics.BULTEN
Q2 202516 Nov 2025 - Q3 sales fell 22.4% from a customer cyber attack, but new contracts and restructuring support recovery.BULTEN
Q3 202521 Oct 2025